ContractClinical Trial Agreement • October 27th, 2014
Contract Type FiledOctober 27th, 2014Amendment #1 to Clinical Trial Agreement By and Between Aragon Pharmaceuticals, Inc, Pharmaceutical Research Associates CZ, s.r.o. and Slezská nemocnice v Opavě For ARN-509-003 This Amendment #1 (the “Amendment #1 ) by and among ARAGON PHARMACEUTICALS, INC, with offices at located at 12780 El Camino Real, Suite 301, San Diego, CA 92130 ("Sponsor") and Slezská nemocnice v Opavě, příspěvková organizace with offices located at 470/86, Předměstí 746 01 Opava Czech Republic IČ (company ID number): 47813750, TAX ID: CZ478137505, registered in the Commercial Register in Ostrava, Section Pr, entry 924, represented by MUDr. Ladislav Václavec, MBA, director ("Institution") and Pharmaceutical Research Associates CZ, s.r.o. located at Jankovcova 1569/2c, 170 00 Praha 7, Czech Republic, Company ID No.: 276 36 852, Tax ID No.: CZ27636852, acting by MUDr. Andrea Klč, proxy (“PRA”), an affiliate of Pharmaceutical Research Associates, Inc, 4130 ParkLake Avenue, Suite 400, Raleigh, North Carolina